​
​

Kymera Therapeutics (KYMR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Kymera Therapeutics Revenue Highlights

Latest Revenue (Y)

$78.59M

Latest Revenue (Q)

$3.74M

Kymera Therapeutics Revenue by Period

Kymera Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$78.59M67.84%
2022-12-31$46.83M-35.71%
2021-12-31$72.83M114.00%
2020-12-31$34.03M1059.99%
2019-12-31$2.93M100.00%
2018-12-31--

Kymera Therapeutics generated $78.59M in revenue during NA 2023, up 67.84% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Kymera Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$3.74M-85.42%
2024-06-30$25.65M149.34%
2024-03-31$10.29M-78.52%
2023-12-31$47.88M912.80%
2023-09-30$4.73M-71.37%
2023-06-30$16.51M74.45%
2023-03-31$9.47M-41.35%
2022-12-31$16.14M68.98%
2022-09-30$9.55M-17.05%
2022-06-30$11.51M19.66%
2022-03-31$9.62M-37.01%
2021-12-31$15.28M-24.89%
2021-09-30$20.34M9.81%
2021-06-30$18.52M-0.98%
2021-03-31$18.70M46.28%
2020-12-31$12.79M-12.03%
2020-09-30$14.53M342.00%
2020-06-30$3.29M-4.08%
2020-03-31$3.43M87.02%
2019-12-31$1.83M92.95%
2019-09-30$950.00K-

Kymera Therapeutics generated $3.74M in revenue during Q3 2024, up -85.42% compared to the previous quarter, and up 22.65% compared to the same period a year ago.

Kymera Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KYMRKymera Therapeutics$78.59M$3.74M
NRIXNurix Therapeutics$76.99M$12.59M
FHTXFoghorn Therapeutics$34.16M$7.81M
AGIOAgios Pharmaceuticals$26.82M$8.96M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
IPSCCentury Therapeutics$2.23M$791.00K
STTKShattuck Labs$1.66M$1.61M
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
ELYMEliem Therapeutics--
PRLDPrelude Therapeutics--
MLYSMineralys Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--

KYMR Revenue FAQ

What is Kymera Therapeutics’s yearly revenue?

Kymera Therapeutics's yearly revenue for 2023 was $78.59M, representing an increase of 67.84% compared to 2022. The company's yearly revenue for 2022 was $46.83M, representing a decrease of -35.71% compared to 2021. KYMR's yearly revenue for 2021 was $72.83M, representing an increase of 114.00% compared to 2020.

What is Kymera Therapeutics’s quarterly revenue?

Kymera Therapeutics's quarterly revenue for Q3 2024 was $3.74M, a -85.42% decrease from the previous quarter (Q2 2024), and a -20.88% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $25.65M, a 149.34% increase from the previous quarter (Q1 2024), and a 55.33% increase year-over-year (Q2 2023). KYMR's quarterly revenue for Q1 2024 was $10.29M, a -78.52% decrease from the previous quarter (Q4 2023), and a 8.67% increase year-over-year (Q1 2023).

What is Kymera Therapeutics’s revenue growth rate?

Kymera Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 7.91%, and for the last 5 years (2019-2023) was 2578.66%.